 |
 |
 |
 |
|
|
|
|
Posts Tagged ‘
dementia ’
Introduction
Dr. Geri Adler is Assistant Professor in the Graduate College of Social Work at the University of Houston. She has over twenty years of clinical experience working with individuals with Alzheimer's disease and their families. A Hartford Geriatric Social Work Scholar, Dr. Adler's funded research focuses on driving and dementia. She has multiple publications in this area including recent manuscripts in Dementia: The International Journal of Social Research and Practice, Traffic Injury & Prevention, The Gerontologist and Health and Social Work.
Q. Why is driving and dementia a concern?
Over five million Americans are estimated to have Alzheimer's disease (AD) and related dementias and 30% to 50% of persons with dementia continue to drive. Although some individuals with mild dementia can drive safely, for almost all, driving will become impossible at some point as the disease progresses.
Research has found that drivers with dementia have a higher crash rate, become lost in familiar areas, and make more frequent errors in performance than other older drivers. In addition, because of poor judgment, lack of insight and a loss of reasoning ability some drivers with dementia may not even realize they having any problems. Therefore, individuals with dementia continue to drive when they are no longer able.
Being unable to drive is a serious loss of independence and mobility. It is not unusual for drivers with dementia to become upset, angry and even depressed when driving concerns are raised.
The sheer numbers of persons with dementia who continue to drive, the seriousness of the issue, and its effect on mobility, underscores the importance of addressing driving and dementia.
Q. What are some warning signs of driving problems?
It can be difficult to determine when a driver with dementia is no longer safe to drive. However, there are several warning signs or red flags that may indicate driving skills are declining and need to be evaluated.
Warning signs to watch for include:
- becoming lost in familiar areas,
- incorrect signaling,
- improper speed – driving too slow or too fast for conditions,
- driving the wrong direction on roadways,
- decreased understanding of traffic signs,
- confusing the break and gas pedals,
- reliance on a co-pilot,
- making poor or slow decisions while behind-the-wheel,
- moving violations, tickets or police warnings, and
- crashes or near misses.
Another indicator of problematic driving occurs when family members refuse to ride with the driver or do not allow others, such as grandchildren, to ride with driver.
Q. What are some ways to assess driving fitness and resources for driving decisions?
It is important to discuss driving concerns with a physician and to also have the individual with dementia's driving evaluated. Many physicians are comfortable beginning the discussion about driving reduction and cessation and to start the driving assessment process. The physician may ask the driver and family questions about the frequency, distance, circumstances of travel, familiarity with roadways used, use of a co-pilot, and any recent crashes and episodes of getting lost. Family may also be asked if they have any concerns about their relative's driving.
If there is any question about the individual's ability to drive safety, he or she will benefit further from a formalized evaluation. Testing can be conducted by a certified driver rehabilitation specialist (CDRS), a professional trained in driver education and training, or the State Department of Public Safety. An assessment may include a knowledge test as well as a behind-the-wheel evaluation. There is usually a fee for an assessment completed by a CDRS. Unfortunately, Medicare and private insurance are unlikely to reimburse for this service.
If the evaluation shows that the individual with dementia is able to continue to drive safely, his or her performance must continue to be revisited. Because many dementias are progressive, ongoing management and discussions about driving are needed. Driving modifications may also be suggested such as limit the individual's driving to off-peak or daylight hours, in familiar areas or in less complex driving environments.
If serious driving errors are apparent, the driver will be advised to stop driving. Discussions about "retirement" from driving must be handled sensitively. In order to be successful, family need to be supportive and participate in creating a workable transportation plan for their relative.
If a driver is reluctant to quit driving, different approaches can be considered to facilitate voluntary cessation. First, it is important to explore with the driver, his or her reasons for resistance. A conversation with a person whom the driver respects, such as a clergy or a police officer, may be able to persuade the driver to quit. Insurance ramifications are also important to consider. For some drivers, individual or group support can diminish the loss and provide opportunities to discuss concerns. For others, a prescription stating that the individual should no longer drive can add leverage.
If all fails authoritarian approaches are needed. In those situations, family members may need to disable the vehicle, move it to another location, hide or replace the keys, or even the sell the vehicle.
When an individual can no longer driver, resources for alternative transportation must be identified. Often friends and relatives can provide necessary transportation or can help to locate other options. Conversations with a social worker to identify community supports can be helpful, too. Finally, the person's driver's license should be replaced with an identification card.
Online Resources:
Several helpful booklets and online resources, designed to help family, friends and caregivers of older drivers with driving discussions and decisions include:
###
Related Articles:
Tags: Alzheimer's disease, dementia, Dr. Geri Adler, driving, driving and dementia, driving problems, Geri Adler, social work, social workers, social workers and alzheimer's disease, Three Questions About Driving With Dementia Posted in
Alzheimers Disease/Dementia, Seniors And Aging, Tip Sheets |
No Comments »
Introduction
Over the past few years, Alzheimer’s Disease screening tests have become available to consumers. Licensed clinical social workers who have special training in genetic counseling can help individuals or family members who are interested in these tests. Below is a fact sheet from the Alzheimer’s Association briefly describing the various screening tests.
A screening test is a preliminary procedure administered to distinguish individuals who may need further evaluation for a disorder from those who are less likely to need additional testing. Familiar examples of screening tests include Pap smears, mammograms, and kits for collecting small stool samples to be examined for hidden blood. Most such tests are administered under the supervision of a health care professional who orders the test, communicates the result, and discusses appropriate next steps.
Test developers, health care facilities, and other sources are marketing a growing number of screening tests directly to consumers. Some of these tests are offered on a "self-referred" basis—individuals taking the test do not need a physician's order for it, and the testing facility reports the results directly to the examinee. Self-referred testing is a controversial practice. It is lucrative for facilities administering these tests because consumers must pay for them directly. Insurance plans generally do not pay for self-referred procedures, so facilities offering them can set their own price and require payment in advance.
The Alzheimer's Association has received numerous questions about two dementia screening tests recently marketed directly to consumers. One is the Early AlertAlzheimer's Home Screening Test, available in pharmacies and from a Web site. The other is the Minnesota Cognitive Acuity Screen (MCAS), sold by telephone and through a Web site.
The Alzheimer's Association believes that no single dementia screening procedure is a meaningful substitute for established diagnostic criteria for Alzheimer's disease administered by a skilled physician. Although these screening tests do not claim to offer a definitive diagnosis, any test that may plant the idea of a serious illness in a test-taker's mind has the potential to cause great psychological distress. The whole process of assessment, diagnosis, and diagnostic disclosure should be carried out within the context of an ongoing relationship with responsible health care professionals. Here are some relevant facts about each of the tests currently generating frequent questions:
- This test, marketed by FMG Innovations, Inc., sells for around $15 – $20 in pharmacies and on the Internet.
- It is packaged in a small box that contains an instruction sheet, a pencil, and a booklet with 12 "scratch and sniff" odor strips. Examinees are instructed to scratch each strip to release the smell, then circle one of four words that best describe the odor. Choices include "cinnamon," "dog," "soap," "garlic," "motor oil," fruit and floral fragrances, and a variety of other scents.
- Correct answers are provided in an answer key at the back of the booklet. Examinees with four or more incorrect choices are advised to consult their physician.
- The instruction sheet states, "Smell loss is among the first signs of Alzheimer's disease. Experts recommend screening for smell loss once a year after the age of 65." It is true that there are legitimate scientific investigations exploring a possible link between smell loss and Alzheimer's disease, but the relationship has not been confirmed or quantified. No currently accepted diagnostic criteria for Alzheimer's include evaluation of smell, and there is no recommendation for annual smell testing from any recognized authority involved in establishing clinical guidelines.
- Many factors other than Alzheimer's disease can impair smell, including current smoking or past smoking, certain drugs, a wide variety of medical conditions, and individual differences in sensitivity to odors.
- Medical and diagnostic equipment, including products marketed directly to consumers, is regulated by the Center for Devices and Radiologic Health (CDRH) of the U.S. Food and Drug Administration (FDA). According to a CDRH spokesperson, the Early Alert smell test has not been cleared or approved for marketing.
- The MCAS is sold by telephone and over the Internet for $95 by Nation's CareLink, a care management firm specializing in geriatric assessments.
- The test consists of a 15-minute question-and-answer telephone interview administered by a registered nurse who asks test-takers such questions as their name, address, and birthday, what day it is, and how they would handle an emergency such as a fire in their home. Examinees are also asked to repeat a six-digit number, to remember 10 words, and to tap on the telephone when instructed. Nurses score each examinee, and those whose scores fall below certain levels are considered to need monitoring or to have "failed" the test.
- The test's developers recommend annual testing. This recommendation does not reflect a policy established by any recognized clinical guideline.
- The chief use of the MCAS has been for commercial rather than clinical purposes—the test was developed by Nation's CareLink as a risk management tool to help insurers avoid issuing long-term care policies to individuals judged likely to develop dementia.
- The MCAS Web site describes the test as "98.1 percent effective in identifying cognitive function." In support of this statement, MCAS cites an article published by the test's developers in the October 2000 edition of the journal Neuropsychiatry, Neuropsychology, and Behavioral Neurology. The abstract of this article on PubMed, the on-line literature database for the U.S. National Library of Medicine, concludes with the developer's own statement that "The Minnesota Cognitive Acuity Screen (MCAS) should undergo further study in unselected elderly populations to better understand its value as a screening tool." The PubMed database contains no additional articles about the test.
To receive information about other important issues related to Alzheimer's disease, please call our Contact Center at (800) 272-3900 or visit the Alzheimer's Association Web site at www.alz.org.
Related Articles:
Tags: Alzheimer's disease, dementia, screening Posted in
Alzheimers Disease/Dementia, Current Trends, Seniors And Aging |
No Comments »
Introduction
Over the past few years, Alzheimer’s disease screening tests have become available to consumers. Licensed clinical social workers who have special training in genetic counseling can help individuals or family members who are interested in these tests. Below is a fact sheet from the Alzheimer’s Association briefly describing the various screening tests.
What is a Screening Test?
A screening test is a preliminary procedure administered to distinguish individuals who may need further evaluation for a disorder from those who are less likely to need additional testing. Familiar examples of screening tests include Pap smears, mammograms, and kits for collecting small stool samples to be examined for hidden blood. Most such tests are administered under the supervision of a health care professional who orders the test, communicates the result, and discusses appropriate next steps.
What Screening Tests Are Marketed Directly to Consumers?
Test developers, health care facilities, and other sources are marketing a growing number of screening tests directly to consumers. Some of these tests are offered on a "self-referred" basis—individuals taking the test do not need a physician's order for it, and the testing facility reports the results directly to the examinee. Self-referred testing is a controversial practice. It is lucrative for facilities administering these tests because consumers must pay for them directly. Insurance plans generally do not pay for self-referred procedures, so facilities offering them can set their own price and require payment in advance.
What Consumer Screening Tests Are Marketed for Dementia?
The Alzheimer's Association has received numerous questions about two dementia screening tests recently marketed directly to consumers. One is the Early Alert Alzheimer's Home Screening Test, available in pharmacies and from a Web site. The other is the Minnesota Cognitive Acuity Screen (MCAS), sold by telephone and through a Web site.
The Alzheimer's Association believes that no single dementia screening procedure is a meaningful substitute for established diagnostic criteria for Alzheimer's disease administered by a skilled physician. Although these screening tests do not claim to offer a definitive diagnosis, any test that may plant the idea of a serious illness in a test-taker's mind has the potential to cause great psychological distress. The whole process of assessment, diagnosis, and diagnostic disclosure should be carried out within the context of an ongoing relationship with responsible health care professionals. Here are some relevant facts about each of the tests currently generating frequent questions:
Facts about the Early Alert Alzheimer's Home Screening Test
- This test, marketed by FMG Innovations, Inc., sells for around $15 – $20 in pharmacies and on the Internet.
- It is packaged in a small box that contains an instruction sheet, a pencil, and a booklet with 12 "scratch and sniff" odor strips. Examinees are instructed to scratch each strip to release the smell, then circle one of four words that best describe the odor. Choices include "cinnamon," "dog," "soap," "garlic," "motor oil," fruit and floral fragrances, and a variety of other scents.
- Correct answers are provided in an answer key at the back of the booklet. Examinees with four or more incorrect choices are advised to consult their physician.
- The instruction sheet states, "Smell loss is among the first signs of Alzheimer's disease. Experts recommend screening for smell loss once a year after the age of 65." It is true that there are legitimate scientific investigations exploring a possible link between smell loss and Alzheimer's disease, but the relationship has not been confirmed or quantified. No currently accepted diagnostic criteria for Alzheimer's include evaluation of smell, and there is no recommendation for annual smell testing from any recognized authority involved in establishing clinical guidelines.
- Many factors other than Alzheimer's disease can impair smell, including current smoking or past smoking, certain drugs, a wide variety of medical conditions, and individual differences in sensitivity to odors.
- Medical and diagnostic equipment, including products marketed directly to consumers, is regulated by the Center for Devices and Radiologic Health (CDRH) of the U.S. Food and Drug Administration (FDA). According to a CDRH spokesperson, the Early Alert smell test has not been cleared or approved for marketing.
Facts about the Minnesota Cognitive Acuity Screen (MCAS)
- The MCAS is sold by telephone and over the Internet for $95 by Nation's CareLink, a care management firm specializing in geriatric assessments.
- The test consists of a 15-minute question-and-answer telephone interview administered by a registered nurse who asks test-takers such questions as their name, address, and birthday, what day it is, and how they would handle an emergency such as a fire in their home. Examinees are also asked to repeat a six-digit number, to remember 10 words, and to tap on the telephone when instructed. Nurses score each examinee, and those whose scores fall below certain levels are considered to need monitoring or to have "failed" the test.
- The test's developers recommend annual testing. This recommendation does not reflect a policy established by any recognized clinical guideline.
- The chief use of the MCAS has been for commercial rather than clinical purposes—the test was developed by Nation's CareLink as a risk management tool to help insurers avoid issuing long-term care policies to individuals judged likely to develop dementia.
- The MCAS Web site describes the test as "98.1 percent effective in identifying cognitive function." In support of this statement, MCAS cites an article published by the test's developers in the October 2000 edition of the journal Neuropsychiatry, Neuropsychology, and Behavioral Neurology. The abstract of this article on PubMed, the on-line literature database for the U.S. National Library of Medicine, concludes with the developer's own statement that "The Minnesota Cognitive Acuity Screen (MCAS) should undergo further study in unselected elderly populations to better understand its value as a screening tool." The PubMed database contains no additional articles about the test.
Where Can I Get Information About Other Alzheimer-Related issues?
To receive information about other important issues related to Alzheimer's disease, please call our Contact Center at (800) 272-3900 or visit the Alzheimer's Association Web site at www.alz.org.
Related Articles:
Tags: Alzheimer's disease, dementia, genetic screening Posted in
Family Genetics, Health And Wellness, Your Options |
No Comments »
As we age, most of us will experience temporary memory lapses. We may forget names or telephone numbers and have difficulty finding the right word, which can be annoying, but certainly not life threatening. More serious memory problems and behavioral changes that interfere with daily life are not normal and may indicate a brain disease called dementia.
Dementia is a group of symptoms caused by changes in brain function, according to the National Institute on Aging. Alzheimer's disease, the most common form of dementia that is seen in older adults, is a progressive brain disorder that affects memory and reasoning and the ability to learn and communicate.
The onset of the disease is gradual, so older adults, their families, and even their doctors may not initially consider early symptoms as a possible form of dementia. Once diagnosed with the illness, people with Alzheimer's live an average of eight years, although they can live as long as 20 years with the disease, depending on the age at diagnosis and the severity of other health problems.
Alzheimer's is most common in people over age 65. An estimated 4.5 million people in the United States have been diagnosed with Alzheimer's.
The Alzheimer's Association estimates that by 2050, the number of people with the disease could increase to range from 11 to 16 million.
The disease is often categorized into early, middle, and late stages. Not everyone with the disease will develop all of the symptoms or experience a decline in the same amount of time. The Alzheimer's Association describes the stages in terms of symptoms.
- Frequent memory loss: forgetting recent events and conversations
- Problems with language: forgetting simple words or making up words as substitutes
- Difficulty performing everyday tasks, such as cooking or paying bills
- Disorientation to time and place: forgetting where they are, how they got there, and how to get home
- Mood changes: rapid mood swings for no apparent reason
- Personality changes: becoming unusually angry, irritable, quiet, or confused
Difficult behaviors: paranoia, wandering, repeating questions, hallucinations, agitation
- Loss of reading and writing abilities
- Loss of coordination
- Difficulty recognizing family and friends at times
- Progresses from needing reminders regarding personal care to needing assistance with personal care
- Loss of ability to walk, communicate, and to recognize people and objects
- May lose ability to swallow
- Incontinence
- Spends majority of time sleeping
Alzheimer's disease cannot be diagnosed with a single test or procedure. Instead, the disease is diagnosed through comprehensive neurological assessments and a medical evaluation. Physicians will rule out other potential causes of dementia symptoms, including depression, malnutrition, or side effects from medications.
There is no known cure for Alzheimer's, but several medications have been developed recently for people in the early stages of the disease to aid in slowing down the progression of the disease. However, the new medications are not effective for everyone.
Depression, anxiety, unpredictable behavior, and other emotional and behavioral symptoms can also be treated with medication to help improve the quality of life of people with Alzheimer's and their caregivers.
According to the Alzheimer’s Association, early-onset is a diagnosis of the disease when the person is younger than 65. A small percentage of individuals are diagnosed in the 40′s, 50′s and early 60′s. Individuals with early-onset may be employed, have children living at home and face issues such as ensuring financial security, obtaining benefits, and helping children cope with the disease.
Watching a loved one slowly deteriorate from one stage of Alzheimer's to the next can be devastating for family members. Caregivers must adjust over time as the needs of the person with Alzheimer's disease change, cope with challenging behavioral changes, and experience the heartache when their loved one no longer recognizes them.
Nearly all Alzheimer's caregivers report that they frequently experience high levels of stress, and nearly half suffer from depression, according to the Alzheimer's Association. Caregivers often ignore their own health needs due to the demands of their caregiving role.
To reduce caregiver stress, the Alzheimer's Association offers these suggestions:
- Learn about the disease: symptoms, behavioral changes, and stages
- Find classes that will teach you how to control unwanted behaviors and improve communication
- Find a support group in your community for information and emotional support
- Establish a social and emotional support network of people you can count on to help in times of need
- Plan ahead for legal and financial issues
- Take care of your own physical and emotional needs
Social workers who work in health care settings, social service organizations, and private practice are trained to assist caregivers with family needs during this difficult time. They can arrange for in-home services, coordinate care among medical professionals, and direct caregivers to various community resources, particularly respite care, which is necessary to reduce caregiver stress.
When caregivers care for themselves, seek help, and participate in support groups and classes, they are more equipped to provide better care and to care for their loved one at home through the later stages of the disease.
Related Articles:
Tags: Alzheimer's disease, dementia Posted in
About, Alzheimers Disease/Dementia, Seniors And Aging |
No Comments »
 Tim Malone, a social worker who specializes in the mental health of seniors, listens to Mildred “Midge” Fitz during a visit to Aspen Ridge Retirement Community’s Alzheimer’s Care facility. Malone tries to help Aspen Ridge staff determine what is causing Fitz’s pain. Rob Kerr / The Bulletin
|
|
If not for Tim Malone, 86-year-old William Baldridge would spend most of his time alone in the small home he built on an expanse of juniper and sagebrush near Bend.
Baldridge tries to keep in touch with the outside world by writing letters to his children, who live out of the area. But most days his mailbox is empty.
“The mail is like a dead lizard, it don’t appear,” Baldridge said recently, during one of Malone’s weekly visits to check on his client’s health and well being.
Malone, 52, is a social worker specializing in senior mental health. As supervisor of the Deschutes County Mental Health Senior Program, Malone has built a five-person team that treats seniors with disorders ranging from minor depression to severe dementia and chronic mental illnesses like schizophrenia and bipolar disorder.
Malone and his team also counsel clients on adjusting to daily living as they age, from losing their driver’s license to being alone.
“We help them to adjust to and to accept their needs,” said Malone. “We make things OK.”
Of the 32 million Americans aged 65 and older, five million suffer from depression, according to the American Association of Geriatric Psychiatry Web site.
Depression, anxiety, dementia and substance abuse are often misdiagnosed or not recognized by primary and specialty care physicians. Left untreated, depression in seniors can cause unnecessary disability, excess health care costs and even death, according to the Web site.
Fifteen percent of Deschutes County’s population is made up of seniors — higher than the national average of 13 percent. In Crook and Jefferson counties the number is even higher at close to 19 percent.
For Malone and the others on the senior mental health team, advocating for elderly patients and their families is not a 9-to-5 job. There are emergency, late-night consultations with doctors, nursing homes and caregivers, trips to the hospital and other interventions.
Malone often takes Baldridge to doctor’s appointments, helps him figure out his medical bills and listens to his tales of old time logging camps, trapping coyotes and politics.
“I’ve essentially befriended him, and him me. So he kind of depends on me at this point,” said Malone.
On a recent weekend, Malone, who once worked as a telephone technician, installed a phone near Baldridge’s bed so he would not have to get up to call for help.
“It’s just a service mental health does, telephone work,” joked Malone.
Malone spends much of his work day zipping from place to place in his compact gold Toyota. After a recent visit with Baldridge, Malone drove to Bend’s Aspen Ridge Retirement Community’s Alzheimer’s Care facility for a consultation.
At Aspen Ridge, Administrator Adele Lavoie briefed Malone on 92-year-old resident Mildred Fitz, who was distraught over pain in her chest and legs. Doctors, however, could not find anything physically wrong with her.
According to Malone, depression can cause somatic illnesses. “It’s very difficult to discern what’s physical and what’s mental, but it’s key for good care for these folks,” said Malone, as he poured over Fitz’s chart in the Aspen Ridge day room.
Malone and Fitz sat outside her room at Aspen Ridge, where he asked her some simple questions, like what she likes to eat and where she grew up, to assess her state of mind.
During their conversation, Fitz repeatedly rubbed her chest and legs with her hands, and complained of pain. But Malone’s attention did get Fitz to smile.
“A lot of them like somebody like me talking to them because I’m addressing their complaints,” said Malone. “She had an opportunity to talk about what was wrong with her.”
Malone said he hopes that his assessment will help uncover the source of Fitz’s pain, but there are no guarantees. There are often complex psychological and physical factors at work.
“(Diagnosis) takes a lot of training and a lot of time and experience. If you get it right one out of 10 times, you’ve achieved expert status,” said Malone.
Malone does consultations at Aspen Ridge for four hours each month. In addition to seeing residents, he educates staff on dementia and helps prevent caregiver burnout by teaching staff how to better care for themselves and their patients.
“The more they know the more creative they can be in terms of interventions,” said Malone. “A lot of newer staff think these people are trying to manipulate them to get something. A demented person can’t manipulate, that’s an executive function.”
Curiosity at a young age
Growing up in Detroit, Malone spent a lot of time with the elderly Polish immigrants in his neighborhood, rather than play with other children.
“I ran errands for them, they gave me a dime or something to do it,” Malone said. “I always wanted them to be telling me things. I’ve always been curious about why people do the things they do.”
After serving in the U.S. Coast Guard during the Vietnam War and working as a Merchant Marine, a railroad laborer and a telephone technician, Malone’s lifelong curiosity and desire to help others finally steered him toward a career in social work at the age of 35.
While earning his master’s degree in social work at Portland State University, Malone interned at programs for teens, disabled adults and domestic violence victims. But something clicked during a 1992 internship as a social worker at an older adult day treatment center for veterans in Vancouver, Wash.
“I was the kid who hung out with the old people in the neighborhood,” Malone said. “It kind of flowed right in and I realized this was the match.”
Now, Malone has become part of the lives of many of Deschutes County’s elderly — even if they did not initially want him there.
Malone recalled one client, an elderly Polish woman, who became so depressed and lonely that she wouldn’t leave her home or open her door to Meals on Wheels.
When the alarmed Meals on Wheels personnel called Malone, he went to the woman’s home and knocked on her door. When she opened the door a crack, Malone said he stuck his foot in the jamb, threw the door wide open and told her, “I’m not going to let you die!”
Using a few Polish phrases he picked up in Detroit, Malone eventually convinced the woman to meet him weekly for coffee. Through their meetings, he learned how she and her husband, a Polish Air Force hero, had escaped Europe during World War II.
Another favorite client wanted to will her estate to Malone when she discovered that she was dying of cancer. Instead, Malone helped her locate a distant relative who operated an orphanage in Ethiopia. Eventually, Malone helped his dying client donate her estate to build a hospital wing for the orphanage.
Senior advocate
When Malone was hired to work in Deschutes County in 1993, he became the only employee in the county’s senior mental health department. With the cooperation of county commissioners, Malone hired others like Pat Kroll, who left her job at a resident care center in Redmond to work with Malone.
“He just had such genuine concern for the aging process and the things that people go through as they age,” said Kroll. “When I met him, I said, ‘This is a job I want to do. Do you have an opening?’ ”
With more funding cuts expected from Salem, Malone worries that he may lose staff and further reduce the number of new clients.
“We only get a certain amount of money to do the job. It’s a major constraint because I can’t just help everybody who needs help,” said Malone. “You’ve got to triage.”
On a recent afternoon at his office in Bend, Malone had to turn away a woman seeking help with her elderly mother. When Malone cannot offer help, he refers callers back to their physician or to private mental health care providers, none of whom take Medicare as payment. He also refers people to the Central Oregon Council On Aging and other local senior services.
“There’s a pretty good senior care network here in Deschutes County,” said Malone. “The one big niche that isn’t filled is private senior mental health. The primary reason is that Medicare doesn’t pay.”
According to Malone, the state budget crisis may place the future of senior mental health care in Deschutes County — and elsewhere — in jeopardy.
“It’s completely the wrong direction,” said Malone, of the cuts.
“The senior population is growing while the services being provided are getting smaller.”
Despite state health care funding cuts, Malone, who is vice chairman of the Governor’s Commission on Senior Services, continues to lobby legislators in Salem to increase services for seniors in Deschutes County.
“I know (the legislators) and I’m constantly bugging them. It keeps Deschutes County on the map,” said Malone. “I’m quick to advocate for seniors in general, but ours in particular,” he said.
Alisa Weinstein can be reached at 541-504-2336 or at aweinstein@bendbulletin.com
Tags: Alisa Weinstein, dementia, misdiagnosed, real life story, seniors, social worker, Tim Malone, winter blues Posted in
Depression |
No Comments »
|
|
|
 |
 |
 |
 |
| |
| | |